We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Automated Modular Platform Processes Nucleic Acids and Proteins

By Labmedica staff writers
Posted on 07 Feb 2008
A novel modular platform offers laboratories a new level of flexibility and safety in automated processing of a broad range of samples. More...


Called the QIAsymphony SP, the platform allows users to load samples in different formats, and to isolate, purify, and prepare target analytes for analysis. This step is the most challenging of any molecular analysis. QIAsymphony SP was designed to meet a labs' flexibility and workflow needs. The system can handle a large variety of starting materials and a wide range of input volumes. More than 40 protocols to process DNA, RNA, and proteins have been optimized for use on the platform.

QIAsymphony SP is the first system in Qiagen's (Frankfurt, Germany) new series of modular instruments that can be integrated to automate entire workflows. The novel platform is the result of the largest development program ever undertaken at Qiagen.

The system incorporates many new features such as processing continuous sample racks, reagents, and consumables, and has the ability to perform several purification procedures on one batch of samples by reloading reagents. The system has a wide bandwidth of throughput settings, from a few a day to several hundred. The most complicated processes can be operated by a novice and there is no need retrain laboratory staff. Convenient touch screen operations and bar codes allow easy tracking of reagents, guaranteeing maximum safety and reproducible results.

QIAsymphony SP received the New Product Award (NPA) Designation of the Association for Laboratory Automation (ALA; Geneva, IL, USA). The award was presented to Qiagen on January 29, 2008, at LabAutomation in Palm Springs, CA (USA); an international conference and exhibit for laboratory technologies, where QIAsymphony SP was officially launched on January 28.



Related Links:
Qiagen
Association for Laboratory Automation

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Age-Based Genetic Testing May Miss Most Inherited Cancer Risk Variants

Inherited cancer risk can influence diagnosis, treatment planning, and family screening, yet current testing practices often depend on a patient’s age at diagnosis. Many patients undergo germline genetic... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.